Ignite Creation Date:
2024-05-06 @ 11:07 AM
Last Modification Date:
2024-10-26 @ 12:40 PM
Study NCT ID:
NCT03438006
Status:
COMPLETED
Last Update Posted:
2021-09-08
First Post:
2018-02-13
Brief Title:
A Post Marketing Surveillance PMS Study to Monitor the Safety of GlaxoSmithKline GSK Biologicals Human Papillomavirus HPV Vaccine in Female Chinese Subjects
Sponsor:
Organization:
GlaxoSmithKline
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
3016
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 46649 |
Who Masked List: